Medical Properties Trust, Inc. (MPW)
NYSE: MPW · Real-Time Price · USD
4.050
-0.100 (-2.41%)
At close: Aug 15, 2025, 4:00 PM
4.040
-0.010 (-0.25%)
After-hours: Aug 15, 2025, 7:59 PM EDT
Medical Properties Trust Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Medical Properties Trust stock ranges from a low of $4.00 to a high of $9.00. The average analyst price target of $5.67 forecasts a 40.00% increase in the stock price over the next year.
Price Target: $5.67 (+40.00%)
Analyst Consensus: Hold
* Price targets were last updated on Jun 30, 2025.
Analyst Ratings
The average analyst rating for Medical Properties Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 3 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Hold Maintains $5 → $4.5 | Hold | Maintains | $5 → $4.5 | +11.11% | Jun 30, 2025 |
Exane BNP Paribas | Exane BNP Paribas | Hold → Buy Upgrades $5 → $9 | Hold → Buy | Upgrades | $5 → $9 | +122.22% | Mar 12, 2025 |
RBC Capital | RBC Capital | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | +23.46% | Mar 10, 2025 |
Wells Fargo | Wells Fargo | Sell Maintains $4 → $5 | Sell | Maintains | $4 → $5 | +23.46% | Mar 10, 2025 |
Truist Securities | Truist Securities | Hold Maintains $6 → $4 | Hold | Maintains | $6 → $4 | -1.23% | Dec 19, 2024 |
Financial Forecast
Revenue This Year
949.45M
from 1.04B
Decreased by -8.59%
Revenue Next Year
1.01B
from 949.45M
Increased by 6.17%
EPS This Year
-0.04
from -4.02
EPS Next Year
0.17
from -0.04
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.1B | 1.2B | 1.2B |
Avg | 949.5M | 1.0B | 1.1B |
Low | 865.0M | 911.8M | 979.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 10.5% | 21.3% | 14.8% |
Avg | -8.6% | 6.2% | 6.2% |
Low | -16.7% | -4.0% | -2.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.25 | 0.29 | 0.28 |
Avg | -0.04 | 0.17 | 0.24 |
Low | -0.18 | 0.13 | 0.20 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | 63.5% |
Avg | - | - | 36.9% |
Low | - | - | 13.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.